|
Published by: Frost & Sullivan
Published: Apr. 1, 2002
Table of Contents
1. Executive Summary
A. Executive Summary
1. Executive Summary
2. Introduction
A. Overview
1. Scope and Segmentation
2. Disease Definition And Pathogenesis
3. Types of Osteoporosis
4. Risk Factors
5. Symptoms
6. Diagnosis
7. Prevention and Treatment
8. Cost of Osteoporotic Fractures
9. Challenges
10. Market Drivers
11. Market Restraints
B. Market Dynamics
1. Demand Analysis
2. Market and Technology Trends
C. Strategic Recommendations
1. Strategies Overview
2. Strategic Recommendations for Market Challenge 1
3. Strategic Recommendations for Market Challenge 2
4. Strategic Recommendations for Market Challenge 3
D. Frost & Sullivan Market Engineering Awards
1. Technology Innovation Award
2. Strategic Alliance Innovation Award
3. Technology Leadership Award
4. Business Development Strategy Award
5. Product Line Strategy Award
3. Estrogen Replacement Therapy Market
A. Overview
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Market Share Analysis
3. Product Analysis-Existing
4. Product Analysis-Emerging
4. Biphosphonates Market
A. Overview
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Market Share Analysis
3. Product Analysis-Existing
4. Product Analysis-Emerging
5. Selective Estrogen Receptor Modulator Market
A. Overview
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Market Share Analysis
3. Product Analysis-Existing
4. Product Analysis-Emerging
6. Calcitonin Market
A. Overview
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Market Share Analysis
3. Product Analysis-Existing
4. Product Analysis-Emerging
7. Other Emerging Osteoporosis Therapeutics Market
A. Overview
1. Introduction
2. Market Engineering Analysis
B. Forecasts and Trends
1. Revenue Forecasts
2. Pricing Trends
C. Competitive Analysis
1. Competitive Structure
2. Product Analysis
List of Figures
Chapter 2
Emerging Osteoporosis Therapeutics Markets: Leading Risk Factors For Women And Men (U.S.), 2001
Emerging Osteoporosis Therapeutics Markets: Total Number of Osteoporotic Fractures (U.S.), 2001
Emerging Osteoporosis Therapeutics Markets: Cost Of Osteoporotic Fractures (U.S.), 2001
Emerging Osteoporosis Therapeutics Markets: Impact of Top Ten Industry Challenges (U.S.), 2001-2008
Emerging Osteoporosis Therapeutics Markets: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Emerging Osteoporosis Therapeutics Markets: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Emerging Osteoporosis Therapeutics Markets: Total Population Forecast By Age Group (U.S.), 2001-2008
Emerging Osteoporosis Therapeutics Markets: Population Forecast By Gender And Age Group (U.S.), 2001-2050
Emerging Osteoporosis Therapeutics Markets: Low Bone Mass And Osteoporosis Prevalence By Gender In People Aged 50 And Over (U.S.), 2001-2020
Emerging Osteoporosis Therapeutic Markets: Strategies Addressing Market Challenges (U.S.), 2001
Chapter 3
Estrogen Replacement Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Estrogen Replacement Therapy Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Estrogen Replacement Therapy Market: Revenue Forecast (U.S.), 1998-2008
Estrogen Replacement Therapy Market: Revenue Forecast By Product Class (U.S.), 1998-2008
Estrogen Replacement Therapy Market: Percentage Of Revenues By Product Class (U.S.), 1998-2008
Estrogen Replacement Therapy Market: Product Pricing - Oral ERT(U.S.), 2001
Estrogen Replacement Therapy Market: Product Pricing-ERT Patches (U.S.), 2001
Estrogen Replacement Therapy Market: Monthly Cost Of Treatment-Oral ERT (U.S.), 2001
Estrogen Replacement Therapy Market: Monthly Cost Of Treatment-ERT Patches (U.S.), 2001
Estrogen Replacement Therapy Market: Competitive Structure (U.S.), 2001
Estrogen Replacement Therapy Market: Market Share Analysis (U.S.), 2000-2001
Estrogen Replacement Therapy Market: Product Analysis-Existing Oral (U.S.), 2001
Estrogen Replacement Therapy Market: Product Analysis-Existing ERT Patches (U.S.), 2001
Estrogen Replacement Therapy Market: Product Analysis-Emerging (U.S.), 2001
Chapter 4
Biphosphonates Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Biphosphonates Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Biphosphonates Market: Revenue Forecast (U.S.), 1998-2008
Biphosphonates Market: Product Pricing (U.S.), 2001
Biphosphonates Market: Monthly Cost Of Treatment (U.S.), 2001
Biphosphonates Market: Competitive Structure (U.S.), 2001
Biphosphonates Market: Market Share Analysis (U.S.), 2000-2001
Biphosphonates Market Therapeutics Market: Product Analysis-Existing (U.S.), 2001
Biphosphonates Market: Product Analysis-Emerging (U.S.), 2001
Chapter 5
Selective Estrogen Receptor Modulator Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Selective Estrogen Receptor Modulator Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Selective Estrogen Receptor Modulator Market: Revenue Forecast (U.S.), 1998-2008
Selective Estrogen Receptor Modulator Market: Product Pricing (U.S.), 2001
Selective Estrogen Receptor Modulator Market: Monthly Cost Of Treatment (U.S.), 2001
Selective Estrogen Receptor Modulator Market: Competitive Structure (U.S.), 2001
Selective Estrogen Receptor Modulator Market: Market Share Analysis (U.S.), 2000-2001
Selective Estrogen Receptor Modulator Market: Product Analysis-Existing (U.S.), 2001
Selective Estrogen Receptor Modulator Market: Product Analysis-Emerging (U.S.), 2001
Chapter 6
Calcitonin Market: Market Drivers Ranked in Order of Impact (U.S.), 2001-2008
Calcitonin Market: Market Restraints Ranked in Order of Impact (U.S.), 2001-2008
Calcitonin Market: Revenue Forecast (U.S.), 1998-2008
Calcitonin Market: Product Pricing (U.S.), 2001
Calcitonin Market: Monthly Cost Of Treatment (U.S.), 2001
Calcitonin Market: Competitive Structure (U.S.), 2001
Calcitonin Market: Market Share Analysis (U.S.), 2000-2001
Calcitonin Market: Product Analysis-Existing (U.S.), 2001
Calcitonin Market: Product Analysis-Emerging (U.S.), 2001
Chapter 7
Other Emerging Osteoporosis Therapeutics Market: Revenue Forecast (U.S.), 1998-2008
Other Emerging Osteoporosis Therapeutics Market: Competitive Structure (U.S.), 2001
Other Emerging Osteoporosis Therapeutics Market: Product Analysis (U.S.), 2001
AbstractLack of Disease Awareness Restrains Industry Growth
Many doctors and potential patients remain unaware of the signs of
osteoporosis, which is characterized by low bone mass and structural
deterioration of bone tissue. Consequently, only one-third of the 10 million
Americans suffering from this progressive disease are diagnosed and treated
for their condition. As long as awareness remains low, markets for
therapeutics will fall short of their revenue potential.
This Frost & Sullivan study analyzes the U.S. markets for osteoporosis
therapeutics, including markets for estrogen replacement therapy (ERT),
biphosphonates, selective estrogen receptor modulators, calcitonin, and other
emerging therapies. By examining market drivers and restraints and by
presenting expert revenue forecasts for each segment, this study gives its
readers key insights into the future of this field.
Product Differentiation Is Crucial to Introducing New Therapies
"Drug companies with novel drugs in the pipeline for the prevention and
treatment of osteoporosis are challenged to differentiate their new products
from existing therapies," says the study’s author. Because estrogen therapies,
for example, are viewed as clinically similar, doctors tend to pass over new
products for drugs that they regularly prescribe.
"Until market participants can successfully differentiate their products from
those of their competitors, they will not succeed in unseating traditional
market leaders," states the analyst. This study, which highlights industry
challenges and provides extensive strategic recommendations, can help your
firm increase its market presence.
Bone Formation Drugs Promise New Opportunities
Existing anti-resorptive therapies are unable to replace lost bone or rebuild
new bone mass. As a result, patients with severe osteoporosis are at a very
high risk of developing fractures. Drug companies have responded to this
unmet medical need by developing bone formation drugs, such as the
parathyroid hormone, which have the potential to reverse bone loss and
rebuild bone density in patients with advanced osteoporosis.
"The development of bone formation drugs will revolutionize the osteoporosis
market. Demand will be high among patients who have failed existing therapies,"
says the author. This study tracks the progress of new therapies to enable your
company to optimize its research and development efforts.
Get Full Details About This Report >>
|
